Cargando…

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing

From 2015, Norway has implemented high‐risk human papilloma virus (hrHPV) testing in primary screening for cervical cancer. Women aged 34–69 years, living in four counties, have been pseudo‐randomly assigned (1:1 randomization) to either hrHPV testing every 5 years (followed by cytology if hrHPV is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreassen, Trude, Hansen, Bo T., Engesæter, Birgit, Hashim, Dana, Støer, Nathalie C., Tropé, Ameli, Moen, Kåre, Ursin, Giske, Weiderpass, Elisabete
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Cancer Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590646/ https://www.ncbi.nlm.nih.gov/pubmed/30549273 http://dx.doi.org/10.1002/ijc.32067

Ejemplares similares

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
por: Hashim, Dana, et al.
Publicado: (2020)

HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions
por: Ilisiu, Minodora Bianca, et al.
Publicado: (2019)

Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention
por: Lönnberg, Stefan, et al.
Publicado: (2016)

Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women
por: Løfling, Lukas, et al.
Publicado: (2023)

Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway
por: Leinonen, Maarit K., et al.
Publicado: (2017)

Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing
por: Botteri, Edoardo, et al.
Publicado: (2022)

Impact of HPV vaccination on outcome of cervical cytology screening in Denmark—A register‐based cohort study
por: Thamsborg, Lise Holst, et al.
Publicado: (2018)

Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study
por: Andreassen, Bettina Kulle, et al.
Publicado: (2019)

The burden of colon cancer attributable to modifiable factors—The Norwegian Women and Cancer Study
por: Lukic, Marko, et al.
Publicado: (2022)

Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
por: Löfling, L. Lukas, et al.
Publicado: (2023)

Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study
por: Orumaa, Madleen, et al.
Publicado: (2022)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway
por: Botteri, Edoardo, et al.
Publicado: (2017)

Challenges in assessing the sunscreen‐melanoma association
por: Rueegg, Corina S., et al.
Publicado: (2019)

Human papilloma virus genotyping for the cross‐sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more
por: Del Mistro, Annarosa, et al.
Publicado: (2018)

International variation in the prevalence of preclinical colorectal cancer: Implications for predictive values of noninvasive screening tests and potential target populations for screening
por: Krilaviciute, Agne, et al.
Publicado: (2017)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Frequency and diagnostic outcome of bilateral recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2020)

Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study
por: McBride, Emily, et al.
Publicado: (2019)

Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening program
por: Breekveldt, Emilie C. H., et al.
Publicado: (2022)

Benefit‐to‐harm ratio of the Danish breast cancer screening programme
por: Beau, Anna‐Belle, et al.
Publicado: (2017)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Estimating the Effect of Targeted Screening Strategies: An Application to Colonoscopy and Colorectal Cancer
por: Thomas, Duncan C.
Publicado: (2017)

The impact of the COVID‐19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020
por: Johansson, Anna L. V., et al.
Publicado: (2022)

Comparison of primary cytology, primary HPV testing and co-testing as cervical cancer screening for Chinese women: a population-based screening cohort
por: Li, Zhi-Fang, et al.
Publicado: (2022)

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study
por: Palmer, T J, et al.
Publicado: (2016)

Mammographic screening debate on study design: a need to move the field forward
por: Ursin, Giske
Publicado: (2012)

Change in mammographic density across birth cohorts of Dutch breast cancer screening participants
por: Napolitano, George, et al.
Publicado: (2019)

The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies
por: Koopmann, Brechtje D. M., et al.
Publicado: (2022)

Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen‐positive women: results from the ESTAMPA study
por: Baena, Armando, et al.
Publicado: (2022)

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

Cervical cancer screening programmes and policies in 18 European countries
por: Anttila, A, et al.
Publicado: (2004)

Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis
por: Campos, Nicole G., et al.
Publicado: (2018)

Human papillomavirus self‐sampling for screening nonattenders: Opt‐in pilot implementation with electronic communication platforms
por: Lam, Janni Uyen Hoa, et al.
Publicado: (2017)

Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases
por: Liu, Yihao, et al.
Publicado: (2020)

Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies
por: Dianatinasab, Mostafa, et al.
Publicado: (2022)

Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women
por: Schoemaker, Minouk J., et al.
Publicado: (2020)

Are international differences in breast cancer survival between Australia and the UK present amongst both screen‐detected women and non‐screen‐detected women? survival estimates for women diagnosed in West Midlands and New South Wales 1997–2006
por: Woods, Laura M., et al.
Publicado: (2016)

Impact of screening on cervical cancer incidence: A population‐based case–control study in the United States
por: Landy, Rebecca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ucbkd61000pqp4eu99n17dkjm